Researchers report that enlarged perivascular spaces—tiny drainage channels in the brain visible on routine MRI—occur more often in people with mild cognitive impairment and correlate with several blood markers of Alzheimer’s (including amyloid and tau). The study reviewed nearly 1,000 scans from a multi-ethnic Singapore cohort and suggests MRI-visible clogged drains could flag higher-risk individuals before major brain damage. Prospective follow-up is needed to confirm whether these imaging signs predict future dementia.
Routine MRI May Reveal Early Alzheimer’s Warning: Blocked Brain 'Drains' Linked to Risk

Changes in tiny brain drainage channels visible on routine MRI scans may offer an early warning sign of Alzheimer’s disease, a new study suggests.
What the Study Found
Researchers analyzing nearly 1,000 brain scans from a multi-ethnic Singapore cohort—including about 350 people without cognitive complaints—found that enlarged perivascular spaces (PVS), small channels that help clear waste from the brain, were more common in people with mild cognitive impairment. On standard MRI sequences these widened channels appear as conspicuous fluid-filled spaces.
The team reported that the presence of enlarged PVS correlated with several blood markers associated with Alzheimer’s pathology: four out of seven blood molecule measurements, including measures related to beta-amyloid plaques and tau tangles. The study, published in the journal Neurology, suggests that routine MRI scans could help flag individuals at higher risk of developing Alzheimer’s before major brain damage occurs.
Why This Matters
Alzheimer’s dementia progressively impairs memory, attention and daily functioning. With global dementia cases projected to rise substantially over the coming decades, low-cost, widely available screening tools could improve early detection and enable earlier interventions.
“These brain anomalies can be visually identified on routine magnetic resonance imaging (MRI) scans performed to evaluate cognitive decline,” said neurologist Nagaendran Kandiah of Nanyang Technological University, Singapore.
Limitations And Next Steps
Although the findings are promising, enlarged PVS on MRI are not a definitive diagnosis of Alzheimer’s. The study is observational and shows association rather than causation. Researchers plan prospective follow-up of the same participants to determine how many progress to Alzheimer’s and whether enlarged PVS reliably predict dementia over time.
Experts caution that further validation across diverse populations and standardized imaging criteria are needed before enlarged PVS can be used in routine clinical risk assessment. If confirmed, however, incorporating PVS assessment into routine MRI interpretation could be a cost-effective adjunct to blood biomarkers and other diagnostic tools.
Bottom Line
Enlarged perivascular spaces on routine MRI scans may represent an accessible early indicator of Alzheimer’s risk, but more research is required to confirm their predictive value and establish clinical guidelines for their use.
Similar Articles

Blood Tests May Predict Dementia Risk Decades Before Symptoms, UVM Study Finds
Researchers at the University of Vermont analyzed a subset of the REGARDS cohort and found that three blood biomarkers — NfL,...

Mayo Clinic Tool Predicts Alzheimer’s Risk Years Before Symptoms — Who’s Most at Risk?
What happened: Mayo Clinic researchers created a model that estimates 10-year and lifetime risk of cognitive decline using br...

Nanoparticles Repair the Blood–Brain Barrier and Reverse Alzheimer’s Signs in Mice
Researchers at IBEC and West China Hospital developed supramolecular nanoparticles that mimic ligands for the LRP1 receptor t...

Microglia Switch Into Protective Mode That Slows Alzheimer’s in Mice — Potential Immunotherapy Target
Researchers using mouse models report that microglia can enter a protective state near amyloid‑beta plaques, characterized by...

Scientists Identify Reversible Tau Clusters That Could Stop Alzheimer’s Before Symptoms Appear
Scientists led by Professor Rei Kurita discovered tiny, soft tau protein clusters that appear before the rigid fibrils linked...

Smelly Gas May Protect Against Alzheimer’s: Johns Hopkins Study Reverses Cognitive Deficits in Mice
The Johns Hopkins team reports that low, physiological levels of hydrogen sulfide may protect aging brain cells and reverse b...

Large MRI Study Maps Five Distinct Brain Epochs Across the Lifespan
A large MRI study of 3,802 people aged from infancy to 90 identified four turning points in brain wiring—near ages 9, 32, 66 ...

Scientists Map Five Distinct 'Eras' of the Human Brain From Birth to 90
The University of Cambridge-led analysis of diffusion MRI from nearly 4,000 people (ages a few months to 90) identifies five ...

Small Amounts of Hydrogen Sulfide Improved Alzheimer’s Signs in Mice, Johns Hopkins Finds
Johns Hopkins researchers report that restoring low, sustained levels of hydrogen sulfide (H 2 S) improved cognitive and moto...

New Study Finds 'Adulthood' Brain Stage Begins Around Age 32 — What That Means for Your Health
The University of Cambridge-led MRI study of 3,802 neurotypical participants identifies five functional brain epochs with tur...

Pinprick blood test could detect diseases up to 10 years before symptoms, new UK Biobank dataset suggests
The UK Biobank and Nightingale Health have released a final dataset of nearly 250 blood metabolites measured in about 500,000...

Old Drug, New Hope: Arginine Reduces Alzheimer’s Plaques and Restores Cognition in Mice
This Japanese study found that orally administered arginine—an amino acid already used in some treatments—reduced amyloid‑bet...

‘Brainquakes’ Detected in Psychotic Disorders Could Reframe How We See Schizophrenia
The study identifies "brainquakes": sudden, recurring disruptions in neural connectivity that are more common in people with ...

Simple Molecule L10 Reverses Alzheimer’s-like Symptoms in Rats by Removing Excess Copper
The study reports that a simple molecule, L10, removes excess copper from beta-amyloid deposits and reverses Alzheimer’s-like...

Common Supplement Reduces Alzheimer’s Protein Clumps in Animal Tests — Promising but Early
Japanese researchers found that oral arginine reduced amyloid-beta plaques and improved behavioural and inflammatory markers ...
